The Company has developed and continues to develop diagnostic kits to detect carbohydrates and carbohydrate derivatives in food and pharmaceutical products. Specific kits are on the market with licensing partners.
New kit formats under development for target molecules. Areas of interest include food and drink adulteration, metabolite detection and the detection of blood borne/tissue markers for trauma and disease.
Trial in progress with the NHS in the UK for the wound diagnostic technology.